Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalamine for Active Microscopic Colitis
NCT00952952Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2007
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in microscopic colitis (MC), sponsored by Mayo Clinic. Started Feb 2007; status: completed.
02
Drugs
Salcrozine
03
Conditions
microscopic colitis (MC)
Beyond the preview
Go deeper on NCT00952952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952952.